CIK 0001157601 · Large accelerated filer
MADRIGAL PHARMACEUTICALS, INC.
Sign in to watch- Ticker
- MDGL
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- Phone
- (267) 824-2827
- Business address
- 1001 CONSHOHOCKEN STATE ROAD, SUITE 2-350, WEST CONSHOHOCKEN, PA
- Former names
- MADRIGAL PHARMACEUTICALS, INC., SYNTA PHARMACEUTICALS CORP
- Open-market buys, last 90 days
- $35,023,032
- in 1 filing
- Open-market sales, last 90 days
- $7,011,938
- in 3 filings, $6.7M under 10b5-1 plans
Net +$28,011,094. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-07-20 | Sibold William John President and CEO | Sale | −153 | $550.01 | $84K | 209,610 |
| 2026-07-20 | Sibold William John President and CEO | Sale | −1 | $550.72 | $551 | 209,609 |
| 2026-07-20 | Sibold William John President and CEO | Sale | −280 | $555.05 | $155K | 209,329 |
| 2026-07-17 | Sibold William John President and CEO | Option exercise | +50,000 | 211,829 | ||
| 2026-07-17 | Sibold William John President and CEO | Option exercise · Performance Restricted Stock Units | −50,000 | 0 | ||
| 2026-06-17 | Taub Rebecca Director | Grant or award | +454 | 452,667 | ||
| 2026-06-17 | Taub Rebecca Director | Grant or award · Stock Option (Right to Buy) | +766 | 766 | ||
| 2026-06-17 | Levy Richard S Director | Grant or award | +454 | 22,469 | ||
| 2026-06-17 | Levy Richard S Director | Grant or award · Stock Option (Right to Buy) | +766 | 766 | ||
| 2026-06-17 | FOUSE JACQUALYN A Director | Grant or award | +454 | 1,551 | ||
| 2026-06-17 | FOUSE JACQUALYN A Director | Grant or award · Stock Option (Right to Buy) | +766 | 766 | ||
| 2026-06-17 | Daly James M Director | Grant or award | +454 | 3,081 | ||
| 2026-06-17 | Daly James M Director | Grant or award · Stock Option (Right to Buy) | +766 | 766 | ||
| 2026-06-17 | Brennan Daniel J. Director | Grant or award | +404 | 1,371 | ||
| 2026-06-17 | Brennan Daniel J. Director | Grant or award · Stock Option (Right to Buy) | +681 | 681 | ||
| 2026-06-17 | BAKER BROS. ADVISORS LP Director | Grant or award | +908 | 203,721 | ||
| 2026-06-17 | BAKER BROS. ADVISORS LP Director | Grant or award | +908 | 1,948,876 | ||
| 2026-06-17 | BAKER BROS. ADVISORS LP Director | Grant or award · Non-Qualified Stock Options (right to buy) | +1,532 | 1,532 | ||
| 2026-06-17 | BAKER BROS. ADVISORS LP Director | Grant or award · Non-Qualified Stock Options (right to buy) | +1,532 | 1,532 | ||
| 2026-06-01 | Soergel David Chief Medical Officer | Sale 10b5-1 | −1,042 | $495.74 | $517K | 10,033 |
Page 3 of 82 · 1,629 trades